Dermata Therapeutics Correlations

DRMA Stock

USD 1.10 0.05 4.35%

The current 90-days correlation between Dermata Therapeutics and Phio Pharmaceuticals Corp is -0.03 (i.e., Good diversification). The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Dermata Therapeutics Correlation With Market

Average diversification

The correlation between Dermata Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.

Moving together with Dermata Stock

0.75	FDMT	4D Molecular Therapeutics	Pair Corr
0.75	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.8	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.63	IVVD	Invivyd	Pair Corr
0.79	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.68	PEPG	PepGen	Pair Corr
0.71	RGNX	Regenxbio	Pair Corr
0.7	ADAP	Adaptimmune Therapeutics	Pair Corr
0.67	AFMD	Affimed NV	Pair Corr
0.61	STOK	Stoke Therapeutics	Pair Corr
0.7	BDTX	Black Diamond Therap	Pair Corr
0.63	COLL	Collegium Pharmaceutical	Pair Corr

Moving against Dermata Stock

0.76	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.65	NAMS	NewAmsterdam Pharma	Pair Corr
0.4	ESLAW	Estrella Immunopharma	Pair Corr
0.35	PMVP	Pmv Pharmaceuticals	Pair Corr
0.34	PHVS	Pharvaris BV	Pair Corr
0.32	MNOV	MediciNova	Pair Corr
0.68	AVTE	Aerovate Therapeutics	Pair Corr
0.62	CRVS	Corvus Pharmaceuticals	Pair Corr
0.62	VREX	Varex Imaging Corp	Pair Corr
0.58	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.42	ABEO	Abeona Therapeutics	Pair Corr
0.4	AGIO	Agios Pharm	Pair Corr

Related Correlations Analysis

	ZURA	PHIO	SONN	ATNF	CDIO	WINT	ENSC	PBLA	BXRX	ZVSA
ZURA		0.4	0.26	0.53	0.01	0.0	-0.16	-0.08	-0.09	0.31	ZURA
PHIO	0.4		0.6	0.03	-0.07	0.2	-0.34	0.34	-0.13	0.44	PHIO
SONN	0.26	0.6		-0.16	-0.07	0.48	-0.57	0.79	0.03	0.8	SONN
ATNF	0.53	0.03	-0.16		-0.06	-0.32	0.2	-0.51	-0.21	-0.2	ATNF
CDIO	0.01	-0.07	-0.07	-0.06		0.54	0.57	0.18	0.7	-0.01	CDIO
WINT	0.0	0.2	0.48	-0.32	0.54		-0.01	0.7	0.82	0.61	WINT
ENSC	-0.16	-0.34	-0.57	0.2	0.57	-0.01		-0.46	0.34	-0.59	ENSC
PBLA	-0.08	0.34	0.79	-0.51	0.18	0.7	-0.46		0.35	0.78	PBLA
BXRX	-0.09	-0.13	0.03	-0.21	0.7	0.82	0.34	0.35		0.27	BXRX
ZVSA	0.31	0.44	0.8	-0.2	-0.01	0.61	-0.59	0.78	0.27		ZVSA
	ZURA	PHIO	SONN	ATNF	CDIO	WINT	ENSC	PBLA	BXRX	ZVSA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BXRX	+ 0.82	WINT
ZVSA	+ 0.8	SONN
PBLA	+ 0.79	SONN
ZVSA	+ 0.78	PBLA
BXRX	+ 0.7	CDIO
PBLA	+ 0.7	WINT

High negative correlations

ZVSA	- 0.59	ENSC
ENSC	- 0.57	SONN
PBLA	- 0.51	ATNF
PBLA	- 0.46	ENSC
ENSC	- 0.34	PHIO
WINT	- 0.32	ATNF

Risk-Adjusted Indicators

There is a big difference between Dermata Stock performing well and Dermata Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dermata Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZURA	3.89	(0.58)	0.00	(0.15)	0.00	0.00	7.95	(7.94)	26.70
PHIO	4.58	(0.30)	0.00	(0.17)	0.00	0.00	11.78	(10.38)	36.22
SONN	4.71	(0.91)	0.00	1.57	0.00	0.00	12.31	(9.79)	37.58
ATNF	12.98	2.62	0.39	0.55	7.26	(25.17)	16.10	(11.29)	358.73
CDIO	6.38	(0.61)	0.00	0.00	0.00	0.00	14.81	(13.16)	57.04
WINT	7.42	(3.90)	0.00	(0.83)	0.00	0.00	12.00	(18.48)	62.78
ENSC	11.62	2.30	0.16	(1.65)	10.13	(19.56)	27.27	(20.00)	184.26
PBLA	7.11	(2.51)	0.00	(1.21)	0.00	0.00	10.70	(17.30)	88.58
BXRX	6.57	(0.59)	0.00	(0.19)	0.00	0.00	8.24	(15.31)	141.24
ZVSA	4.10	(0.85)	0.00	0.52	0.00	0.00	7.57	(9.60)	78.93

Dermata Therapeutics Corporate Management

Maria MBA	Senior Assurance	Profile
Gerald Proehl	President, Founder	Profile
Sean Proehl	Senior Development	Profile
David Hale	CoFounder Director	Profile
Dr MPH	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC